Thanks Scorpio for noting that for sicilia. I would add someone was commenting yesterday that of our recent long ideas, ...

Hi forensic: thanks for the insight into the call. It's really helpful when readers impart what they've observed or lear...

July 19-22 2015, I think Lawrence posted on our calendar some months ago: IAS Vancouver, GILD, Important meeting for G...

Tim, Just off the cuff, what do you make of this...?? BTEBY Licensee- Calimmune "...Twelve weeks after human CD34+ H...

DrKSSMDPhD on Saving Jack Kerouac / Feb 18, 7:12pm

Sayonara Calimmunehttp://www.nature.com/nature/journal/vaop/ncurrent/full/nature14264.html...

Kenny: TT-034 has never been about curing HCV. It is a way to pose as being in HCV to draw investors while simultaneousl...

To Larry McKenna:Thanks for that post about HIV-curing gene therapy and Calimmune and the UC Davis report. I worry t...

For Dr. KSS: Re Calimmune HIV clinical study An SA (Panno blog) article published yesterday cites an ostensibly credib...

omcdac1 on Dawn of the Planet of the TLOGlodytes! / Dec 17, 7:45pm

Researchers are reporting another disappointment for efforts to cure infection with the AIDS virus. Six patients given b...

DrKSSMDPhD on Payola from Portola? / Nov 13, 2:10pm

I'll try to keep emotions out of it, but here's why I don't think buying more Benitec shares here is a good idea:(1)...

DrKSSMDPhD on Ebola: To Parse, Perchance to Parlay / Nov 12, 5:22pm

Not not cynicism Frank. Why should people be turned on by a casserole of raspberry-flavored crow served up as news in Si...

newby3867 on Ebola: To Parse, Perchance to Parlay / Nov 12, 4:12am

Interesting article with Calimmune and David Baltimore mentioned. http://www.dddmag.com/articles/2014/11/fighting-hiv-s...

DrKSSMDPhD on Ebola: To Parse, Perchance to Parlay / Nov 4, 7:30pm

Thanks! Have tried to no avail to find abstract. Not sure if this is mechanism for elite controllers. If it is, Calimmun...

KennyG on Will This Unknown Boston Biotech Make Present Surgical Techniques Obsolete? / Oct 9, 10:23am

Exactly right Tim. The companies that they are doing "partnerships" with are as obscure as Beni, or privately owned as ...

DrKSSMDPhD on Tetchy on Tekmira: Time to Short this RNAi Play? / Oct 5, 3:18pm

Well, I can't resist weighing in. I'm not sure which particular Pannobhaso missive contains this (I went over to that si...

DrKSSMDPhD on Tetchy on Tekmira: Time to Short this RNAi Play? / Sep 25, 7:03pm

Important puzzle piece in T.R. Brown and Calimmune study. Conditioning a stem cell recipient (i.e., with busulfan) does ...

Patrick Peterson on The Gain from Pain Mainly Explained / Sep 8, 2:01pm

An article appeared yesterday on the UT-San Diego site re Calimmune. What I found interesting was the fact that it's au...

GUYS! Benitec!!!! please tell me you have heard of them? ASX:BLT These guys have the technology that Calimmune in the U...

DrKSSMDPhD on A Non-Statin Pill That Really Lowers Cholesterol, Blood Pressure and Inflammation without Side Effects Would be a Good Investment, Right? / Aug 16, 3:24pm

Tim: interesting, but doesn't that really in fact make things all the weirder?On one of Sonic Youth's albums, "Murra...

jonken on A Non-Statin Pill That Really Lowers Cholesterol, Blood Pressure and Inflammation without Side Effects Would be a Good Investment, Right? / Aug 14, 11:04am

Your last sentence there, Doctor, reminds me...didn't you or some other enlightened blogger recently suggest that Beni's...

Patrick Peterson on A Non-Statin Pill That Really Lowers Cholesterol, Blood Pressure and Inflammation without Side Effects Would be a Good Investment, Right? / Aug 8, 10:14am

This article (which was posted on Hot Copper today) doesn't explain the Benitec trades that appear on my screen also thi...

DrKSSMDPhD on Why Regado May be Oversold / Aug 1, 5:04pm

Material cribbed from Science today by Jon Cohen about the state of things as far as an HIV cure. Increasingly it appear...

DrKSSMDPhD on The Gain from Pain Mainly Explained (part one) / Jul 22, 4:29pm

Potential mote of dust in the eye of Calimmune: a study presented yesterday at the Melbourne AIDS conference showed that...

mwh5651 on The Gain from Pain Mainly Explained (part one) / Jul 22, 1:42pm

My guess would be the timeline and Australia's habit of selling the news.... Every piece of good news in this stock as o...

KennyG on The Gain from Pain Mainly Explained (part one) / Jul 16, 11:12am

Benitec gets an honorable mention from SA's Intrepid Investor. He also writes about BLUE, EPZN, SGMO and REGN. The Be...

JosephC on Yellow Eyes, White Powders, and an Unknown Nordic Biotech That May Green Things Up for Investors / Jul 13, 9:59pm

The statement below was released by Calimmune less than a month ago, it refers to their trial. It says that they are "ex...

DrKSSMDPhD on Yellow Eyes, White Powders, and an Unknown Nordic Biotech That May Green Things Up for Investors / Jul 11, 9:32pm

Dave: I truly wish I knew. Generally licensing agreements have gradations, with milestone payments at various stages of ...

davehello7 on Yellow Eyes, White Powders, and an Unknown Nordic Biotech That May Green Things Up for Investors / Jul 11, 9:14pm

Hi Dr KSS : You find out the 133k buyer of RGDO? Benitec has licensing agreement with Calimmune and others using their...

omcdac1 on Yellow Eyes, White Powders, and an Unknown Nordic Biotech That May Green Things Up for Investors / Jul 11, 8:36pm

What i think about DdRNAi technology is other company need licence to use ddrani like Calimmune , uniqure and Revivicor ...

timmuggs on Yellow Eyes, White Powders, and an Unknown Nordic Biotech That May Green Things Up for Investors / Jul 5, 12:43pm

An article in SF Chronicle about stem cell therapies, and funding from the state of CA's pocketbook - $3bn set aside to ...

davehello7 on Hepatitis with a C / Jun 27, 11:59pm

Some Calimmune news in HIV trials licensing Benitec's technologyhttp://www.businesswire.com/news/home/20140625005962...

bupsbups on Hepatitis with a C / Jun 25, 8:22pm

Benitec announcement concerning Calimmune. http://www.asx.com.au/asx/research/companyInfo.do?by=asxCode&asxCode=BLT...

ScorpioRising on Hepatitis with a C / Jun 24, 11:56pm

Great part 2, hopefully someday we'll have a part 3 digging in to the details of Benitec's trial data and what it really...

omcdac1 on Is This Red-Hot New “Blood Stock” Any Bloody Good as an Investment? / Jun 24, 3:05pm

DR KSS, Any idea when Calimmune will start IPO! I am saving $$ for Calimmune Stocks! Thanks...

DrKSSMDPhD on Is This Red-Hot New “Blood Stock” Any Bloody Good as an Investment? / Jun 24, 12:12pm

To John Trier: that paper is an intellectualization of the basis for Calimmune's approach to HIV. Geoff Symonds, one of ...

timmuggs on Of Needles, Haystacks, and the Needle-in-a-Haystack Cancer Diagnostics Nanocap That May Belong in Your Portfolio / Jun 17, 6:05pm

I think it is a good idea, but I think it woulda been better a month ago. Yes I know, I'm a master of the obvious, and y...

Dr. KSS, MD, PhD on Of Needles, Haystacks, and the Needle-in-a-Haystack Cancer Diagnostics Nanocap That May Belong in Your Portfolio / Jun 15, 8:04pm

Here's a closely watched event, and in fact the conference call in the morning may interest some. Blue Bird Bio, which w...

DrKSSMDPhD on Hepatitis with a C: Right Now Someone You Know Has It (and Doesn’t Know) / May 29, 5:55pm

To S Hoffman: that's a fine question, and a nuanced one.For the Calimmune trial, patients get harvesting of stem cel...

hoffpi on Hepatitis with a C: Right Now Someone You Know Has It (and Doesn’t Know) / May 29, 5:35pm

DR. KSS: Thanks again for educating the masses. Assuming relatively healthy subjects, doesn't the ongoing Calimmune ...

biotechlong (btl) on Hepatitis with a C: Right Now Someone You Know Has It (and Doesn’t Know) / May 23, 12:54pm

Here's an interested 5-23 Hot Copper post related (indirectly) to BNIKF:"Prof Anthony Kelleher's team at the Kirby I...

jamespaul108 on Hepatitis with a C: Right Now Someone You Know Has It (and Doesn’t Know) / May 17, 2:56pm

John: Apparently the speaker went on standard drugs, the drug-cocktails that are in common use today that cause HIV vir...

newby3867 on Hepatitis with a C: Right Now Someone You Know Has It (and Doesn’t Know) / May 15, 4:29am

Herbalix when you go to link to Hot Copper,give the I agree box a chance for a few seconds to get blue outline around bo...

newby3867 on Hepatitis with a C: Right Now Someone You Know Has It (and Doesn’t Know) / May 14, 11:19pm

Wow, take a look at this video that I found on Hot Copper at Benitec site of a patient that was treated by Calimmune and...

newby3867 on Guaranteed Weight Loss without Surgery, Drugs or Dieting! (Really!) / May 7, 3:24pm

Could Calimmune be looking to expand clinical trials to Australia? They are looking for a Clinical Trials Manager there...

DrKSSMDPhD on Antibiotics Don’t Get No Respect, But You Can Still Profit From Them / May 1, 3:55pm

To Tmills: I meant to reply to that. No, that isn't the reason, I am sure. Calimmune has already done phase I work with ...

tmills1945 on Antibiotics Don’t Get No Respect, But You Can Still Profit From Them / May 1, 3:47pm

Here is a reiteration of my post 2 nights ago on the Regado thread (#430)...would welcome all thoughts: ...

tmills1945 on In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences / Apr 29, 1:51am

Any information available on the status/results of the Calimmune trial for HIV? Is it possible that Benni is waiting ...

DrKSSMDPhD on In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences / Apr 23, 6:15pm

Om: Yes, Blue Bird has been mentioned a few times and I have meant for a while to sift through it. While this is by no m...

omcdac1 on Another Hot Australian Biotech: Is Biotron Right for Your Portfolio? / Apr 7, 9:18pm

One interesting thing about "DAVID BALTIMORE, Ph.D. (Chairman) " from Calimmune In 1975, he shared the Nobel Prize fo...

omcdac1 on Another Hot Australian Biotech: Is Biotron Right for Your Portfolio? / Apr 7, 9:13pm

We are just ready to buy as soon as Calimmune is public :) Waiting ... eagerly .....

quantum007 on Another Hot Australian Biotech: Is Biotron Right for Your Portfolio? / Apr 7, 9:11pm

Oh wow you guys have sure done a lot of research on Calimmune... Tx Thomas for pointing it out to me, gonna enjoy read...

quantum007 on Another Hot Australian Biotech: Is Biotron Right for Your Portfolio? / Apr 7, 9:04pm

Ya Calimmune is an amazing company... HIV gene therapy transffered via stem cells. These guys are ahead of the curve ...

omcdac1 on Another Hot Australian Biotech: Is Biotron Right for Your Portfolio? / Apr 7, 9:02pm

Please go to this and Search for Calimmune Ctrl + F http://www.stockgumshoe.com/reviews/biotech-supertrader/this-tiny-...

tompaol on Another Hot Australian Biotech: Is Biotron Right for Your Portfolio? / Apr 7, 8:30pm

HI JZ: I am wondering if you have had of your Angel Investors looking at Calimmune. As Dr. KSS has mentioned them they...

Subramania Kaushik on NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It / Apr 4, 10:29am

Here is a post by Pannobhaso on Benitec!"For anyone interested in the science, a related, pre-clinical paper by Cali...

DrKSSMDPhD on NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It / Apr 2, 6:56pm

JZ: Sangamo's is one approach to genetic disease. And a decade ago, one might have argued that its notions versus siRNA ...

vamonos on NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It / Mar 25, 7:56am

Doc here are some viral load results posted from a participant posted on the forum board for Calimmune trials. Note star...

DrKSSMDPhD on NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It / Mar 24, 11:47am

While I am definitely an investor more than a trader, people really really need to look at the technical formation brewi...

Subramania Kaushik on NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It / Mar 23, 12:18pm

Seems like Calimmune trials are going well! Check this instablog by Panno! If we have any news published by Calimmune a...

vamonos on NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It / Mar 22, 10:28pm

To All: our patience will be rewarded soon. Here is the possible participant for cohort 3 in the Calimmune trial posting...

DrKSSMDPhD on NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It / Mar 14, 2:04pm

Randy; Strong work with Calimmune. A bit of a disingenuous slide by Breton in one answer, and he should have elaborated,...

vamonos on NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It / Mar 14, 9:00am

Hi Doc and All: Last nights Oxbridge Biotech Round table event " Is Gene Therapy a risky Buisness" should have been tit...

Randy Trier on The eyes and ears team for bio trials / Mar 11, 9:58pm

I will be there Nick. I will do my best to Channel the good Dr. with the questions he has provided me with. One of the a...

Nature Biotechnology | EditorialIs this really the RNAissance? Nature Biotechnology 32,201(2014)doi:10.1038/nbt.28...

I am going to post this here as it relates to KSS's little jewel. It is copied and pasted from HotCopper as the article...

DrKSSMDPhD on The eyes and ears team for bio trials / Mar 11, 7:20pm

Nature Biotechnology | EditorialIs this really the RNAissance? Nature Biotechnology 32,201(2014)doi:10.1038/nbt.28...

DrKSSMDPhD on NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It / Mar 11, 7:19pm

Good commentary:Nature Biotechnology | EditorialIs this really the RNAissance? Nature Biotechnology 32,201(201...

Hoyland from Hot Copper has posted about Calimmune news. Did a little searching and found the forum thread he was referr...

Alan and Randy: Basically Calimmune is trying to use gene silencing to replicate the Berlin patient without stem cell th...

To All: I have signed up for the OBR Roundup discussion event at the City of Hope. The topic is the future of gene thera...

Hi Karma, from my understanding, the Calimmune trial is a PI/II with the cohorts receiving either Cal-1 alone, or Cal-1 ...

Good points Larry. As I see it, Benitec's TT-034 trial is really a study with outcomes on 2 fronts. One question to be a...

PS- It was not the Calimmune study that uses Benitek technology. We are still waiting for HIV results for that as I und...

To Larry Wright: Thanks for pointing that out. Overall I don't think Sangamo's method is as persuasive as what Benitec's...

To Nick Semuta: Loaded question Nick!Who is the closest to having success in a pure ddRNAi trial ? All b...

To Lee Baker: I have already speculated here and elsewhere that Gilead may be the Big Cool Friend Benitec needs. As I se...

Hi karma, TT-034 was made ready for clinical trials by Pfizer. There is a sufficient amount for the PI/II clinical tria...

To Eric Libovitz; Thanks for posting and for providing the link to that paper. It is lovely! Benitec's shRNA methodolog...

also Benitec licencee, Calimmune, has produced pre-clinical data for its HIV Pl/ll trial http://www.nature.com/article...

Doctor K I have been invested in a company AcelRx Pharmacuetical(ACRX) since early stages.Was wondering if you had a op...

DR KSS thank you very much for your response in CTSO and Vyralytics.I do not own either and you helped me understand eac...

I forgot to also mention that Calimmune have dosed cohort 1 using ddRNAi for HIV as well. This is a therapeutic dose (a...

No idea how I stumbled onto this but started reading. Here is what I found: http://californiastemcellreport.blogspot.c...

Bill: I also think they are clever. The Zn-finger approach is to suppress T-lymphocyte expression of CCR5, the docking p...